European Journal of Endocrinology

Article	Citations
Prevalence of drugs used for chronic conditions after diagnosis of thyroid cancer: a register-based cohort study	625
Synchronous bilateral adrenalectomy for ACTH-independent Cushing's syndrome in children: multidisciplinary management	344
Autophagy markers are decreased in bone of osteoporotic patients: a monocentric comparative study	198
Prevalence and determinants of dyslipidemia in 2338 Dutch childhood cancer survivors: a DCCS-LATER 2 study	136
A larger brown fat volume and lower radiodensity are related to a greater cardiometabolic risk, especially in young men	109
18-year change in serum intact fibroblast growth factor 23 from midlife to late life and risk of mortality: the ARIC Study	87
Ectopic lipid deposition and insulin resistance in patients with GH disorders before and after treatment	83
Compression of the optic chiasm is associated with reduced photoentrainment of the central biological clock	76
Normative cut-offs for polycystic ovary syndrome diagnostic features in adolescents using cluster analysis	76
When selection becomes selection bias	69
Biallelic POC1A variants cause syndromic severe insulin resistance with muscle cramps	63
Primary adrenal insufficiency in patients with CPOX gene mutations	60
Serum diiodotyrosine – a biomarker to differentiate destructive thyroiditis from Graves’ disease	60
Metformin treatment is associated with reduced risk of hypoglycaemia, major adverse cardiovascular events, and all-cause mortality in patients with post-pancreatitis diabetes mellitus: a nationwide co	59
Factors predicting normalization of reproductive hormones after cessation of anabolic-androgenic steroids in men: a single center retrospective study	57
High prevalence of variants in skeletal dysplasia associated genes in individuals with short stature and minor skeletal anomalies	52
Mineralocorticoid receptor antagonists for primary aldosteronism—appropriate or not?	45
Differential effects of sodium–glucose cotransporter 2 inhibitors on cardiovascular and renal outcomes according to renal function: a dose–response meta-analysis involving 10 randomized clinical trial	45
Extensive expertise in endocrinology: adrenal crisis in assisted reproduction and pregnancy	44
Genome-wide analysis of thyroid function in Australian adolescents highlights SERPINA7 and NCOA3	44
Acute hypoglycemia and risk of cardiac arrhythmias in insulin-treated type 2 diabetes and controls	42
Novel GLCCI1-BRAF fusion drives kinase signaling in a case of pheochromocytomatosis	40
Cardiovascular risk in Danish transgender persons: a matched historical cohort study	40
Transcriptional comparison of testicular adrenal rest tumors with fetal and adult tissues	40
Radiotherapy in aggressive or dopamine agonists resistant prolactinomas; is it still worthwhile?	39

Bone strain index for fracture risk assessment in older men—the prospective STRAMBO study	39
Leflutrozole in male obesity-associated hypogonadotropic hypogonadism: Ph 2b double-blind randomised controlled trial	37
Loss of function of FIGNL1, a DNA damage response gene, causes human ovarian dysgenesis	37
Defining benchmark outcomes for transsphenoidal surgery of pituitary adenomas: a multicenter analysis	36
Digital quantification of somatostatin receptor subtypes 2 and 5 in growth hormone–secreting pituitary tumors	35
25-OHD response to vitamin D supplementation in children: effect of dose but not GC haplotype	34
Comment on the 2021 EUGOGO Clinical Practice Guidelines for the Medical Management of Graves’ Orbitopathy	33
Impact of sex hormones on pheochromocytomas, paragangliomas, and gastroenteropancreatic neuroendocrine tumors	32
Primary hyperaldosteronism induces congruent alterations of sodium homeostasis in different skeletal muscles: a 23Na-MRI study	32
Parathyroid hormone in situ measurement in patients with hyperparathyroidism: single-centre experience of 179 patients	32
Soluble alpha klotho—impact of biological variables and reference intervals for adults	32
Prevalence of adrenal rest tumors and course of gonadal dysfunction in a clinical sample of men with congenital adrenal hyperplasia: a longitudinal analysis over 10 years	31
Persistent improvement of bone mineral density up to 20 years after treatment of Cushing’s syndrome	31
Preoperative calcitonin testing improves the diagnosis of medullary thyroid carcinoma in female and male patients	31
Metabolic health during a randomized controlled lifestyle intervention in women with PCOS	30
European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and therapy of glucocorticoid-induced adrenal insufficiency	29
AMH as part of the diagnostic PCOS workup in large epidemiological studies	29
Real-world experience with 11C-methionine positron emission tomography in the management of acromegaly	29
The metabolic syndrome in pediatrics: do we have a reliable definition? A systematic review	28
Subclinical thyroid function and cardiovascular events in patients with atrial fibrillation	28
Correction to: Recombinant human parathyroid hormone (1–84) is effective in CASR-associated hypoparathyroidism	28
The clinical and biochemical significance of 11-oxygenated androgens in human health and disease	28
Healthcare cost and survival in patients with non-functioning pituitary adenoma	27
A simple fragility fracture risk score for type 2 diabetes patients: a derivation, validation, comparison, and risk stratification study	27
C-peptide level concomitant with hypoglycemia gives better performances than insulin for the diagnosis of endogenous hyperinsulinism: a single-center study of 159 fasting trials	27
Using electronic health record data for clinical research: a quick guide	27
Higher peak height velocity in early maturing girls depends on insulin rather than fat mass or IGF-I	26
No need of glucocorticoid dose adjustment in patients with adrenal insufficiency before COVID-19 vaccine	25
Long-term pituitary function and functional and patient-reported outcomes in severe acquired brain injury	24
Influence of smoking on cardiometabolic profile and surgical outcomes in patients with primary aldosteronism: a cohort study	24
Physiological declines in sex steroid exposure in relation to changes in body composition in healthy men—a prospective cohort study	24
Vaginal bleeding in women with ovarian neuroendocrine tumor metastases should not be overlooked	24
Predictors of treatment response in lymphogenic metastasized papillary thyroid cancer: a histopathological study	23
Familial central precocious puberty due to DLK1 deficiency: novel genetic findings and relevance of serum DLK1 levels	23
Early puberty suppression and gender-affirming hormones do not alter final height in transgender adolescents	23
The metabolic phenotype of patients with primary aldosteronism: impact of subtype and sex – a multicenter-study of 3566 Caucasian and Asian subjects	23
Urea-stimulated copeptin: a novel diagnostic approach in polyuria polydipsia syndrome	23
Thyroid strain in pregnancy: a nationwide study of iodine nutrition and thyroglobulin among Faroese pregnant women	23
Prevalence, risk factors, and optimal way to determine overweight, obesity, and morbid obesity in the first Dutch cohort of 2338 long-term survivors of childhood cancer: a DCCSS-LATER study	22
Impact of antiresorptive agents on mortality risk in postmenopausal women with osteoporosis: insights from a nationwide cohort study	22
Diagnostic strategies for central adrenal insufficiency in clinical practice: authors’ response	22
Cabergoline targets multiple pathways to inhibit PRL secretion and increases stromal fibrosis	22
Long-term male fertility after treatment with radioactive iodine for differentiated thyroid carcinoma	22
EXTENSIVE EXPERTISE IN ENDOCRINOLOGY: My quarter century quest to understand the paradox of marrow adiposity	22
Correction to: Long-term effects of primary hyperparathyroidism and parathyroidectomy on kidney function	22
Shrinkage by the third month predicts long-term response of macroprolactinoma after cabergoline	21
Body image concerns in women with polycystic ovary syndrome: a systematic review and meta-analysis	21
Risk of depression in patients with acromegaly in Korea (2006-2016): a nationwide population-based study	21
Magnetic resonance imaging is a valuable tool to evaluate the therapeutic efficacy of burosumab in children with X-linked hypophosphatemia	21
Severe symptomatic hyponatremia in Europe: insights into current clinical practice	21

Uterine changes in transgender men receiving testosterone therapy	20
Uniparental Disomy Leads to a Novel Cause of MC2R-Related Familial Glucocorticoid Deficiency Type 1	20
Growth hormone treatment adjusted for growth hormone sensitivity in idiopathic short stature	20
Primary hyperparathyroidism induces erythropoietin resistance through fibroblast growth factor 23	20
Paraprotein-Induced Spurious Hypercalcaemia: Diagnostic Pitfalls in Two Cases	20
Novel Glial Cells Missing-2 (GCM2) variants in parathyroid disorders	20
A novel somatostatin receptor ligand for human ACTH – and GH –secreting pituitary adenomas	20
Denosumab withdrawal increases vertebral fracture and mortality risk compared with zoledronate	20
HLA investigation in ICI-induced T1D and isolated ACTH deficiency including meta-analysis	19
Outcomes of repeat fineneedle aspiration biopsy for AUS/FLUS thyroid nodules	19
Prognostic value of dysnatremia for survival in neuroendocrine neoplasm patients	19
Pituitary apoplexy in SARS-CoV-2 infected is not necessarily related to the virus	19
Concomitant gut dysbiosis and defective gut barrier serve as the bridges between hypercortisolism and chronic systemic inflammation in Cushing’s disease	19
Saline suppression testing-induced hypocalcemia and implications for clinical interpretations	19
Circulating miR-20a-5p as a biomarker associated with cabergoline responsiveness in patients with hyperprolactinemia and pituitary adenomas	19
Acromegaly and the risk of cancer: a nationwide population-based cohort study in Korea	19
Increased cardiovascular morbidity and reduced life expectancy in a large Italian cohort of patients with resistance to thyroid hormone β (RTHβ)	19
Retraction of: Comparison of finasteride versus flutamide in the treatment of hirsutism	18
Correction to: Somapacitan in children born small for gestational age: a multi-centre, open-label, controlled phase 2 study	18
PRAP study—partial versus radical adrenalectomy in hereditary pheochromocytomas	18
Functional hypogonadism in middle-aged and older men: testosterone treatment or not?	18
‘You cannot expect miracles to happen overnight’: patience pays off when you wish to establish a new adrenocortical carcinoma cell line	18
Sex-specific effect of maternal thyroid peroxidase antibody exposure during pregnancy on 5- to 6-year-old children's cardiometabolic risk score: the Ma'anshan birth cohort study	18
Novel mechanism of pituitary hormone deficiency: genetic variants shift splicing to produce a dominant negative transcription factor isoform	18
Gonadal tumor development in 46,XX disorders of gonadal development	18
Effect of hyponatremia normalization on osteoblast function in patients with SIAD	18
In-depth proteomic signature of parathyroid carcinoma	17
Spleen function is reduced in individuals with NR5A1 variants with or without a difference of sex development: a cross-sectional study	17
Integrative clinical, hormonal, and molecular data associate with invasiveness in acromegaly: REMAH study	17
Polycystic ovary syndrome presents as a multimorbid condition by age 50: birth cohort linkage to national register data	17
NF1gene inactivation acts as a tumor driver inRET/RAS-negative medullary thyroid carcinomas	17
Obesity risk is associated with brain glucose uptake and insulin resistance	17
Adrenal ganglioneuromas: a retrospective multicentric study of 104 cases from the COMETE network	17
Impact of GH administration on skeletal endpoints in adults with overweight/obesity	17
Pituitary apoplexy and SARS-CoV-2 infection: we need to look beyond the acute phase	17
Hyperandrogenaemia, polycystic ovary syndrome, and physical fitness in women—a Northern Finland birth cohort study	17
Long-term outcomes in patients with congenital adrenal hyperplasia treated with hydrocortisone modified-release hard capsules	16
Sexual dimorphism in benign adrenocortical tumours	16
Subgroup analyses in clinical research: too tempting?	16
Non-suppression of renin by renal cysts in a subset of patients with primary aldosteronism—a prospective observational single center study	16
The broad phenotypic spectrum of 17α-hydroxylase/17,20-lyase (CYP17A1) deficiency: a case series	16
Extensive expertise in endocrinology: advances in the management of glucocorticoid-induced osteoporosis	16
Therapeutic management of congenital forms of endocrine hypertension	16
Sex disparities in COVID-19 outcomes of inpatients with diabetes: insights from the CORONADO study	16
How to manage Cushing's disease after failed primary pituitary surgery	16
Target therapy forBRAFmutated anaplastic thyroid cancer: a clinical and molecular study	16
Adrenal wash-out CT: moderate diagnostic value in distinguishing benign from malignant adrenal masses	15
Patients' perspective on the medical pathway from first symptoms to diagnosis in genetic lipodystrophy	15
Improving Diagnosis in Primary Aldosteronism Using HISTALDO and Nodule Size Metrics	15
Bone-active drugs in premenopausal women with breast cancer under hormone-deprivation therapies	15
Cardiovascular risk profile in growth hormone-treated adults with craniopharyngioma compared to non-functioning pituitary adenoma: a national cohort study	15
Randomized controlled trial of Tesomet for weight loss in hypothalamic obesity	15
Serum 25-hydroxy vitamin D and the risk of low muscle mass in young and middle-aged Korean adults	15
KCNJ5 mutations in familial and non-familial primary aldosteronism	15
Clinical and genetic heterogeneity of HNF4A/HNF1A mutations in a multicentre paediatric cohort with hyperinsulinaemic hypoglycaemia	15
ACTH-independent production of 11-oxygenated androgens and glucocorticoids in an adrenocortical adenoma	15
Increased systemic and adipose 11β-HSD1 activity in idiopathic intracranial hypertension	15
Copeptin improves prediction of treatment response in children with monosymptomatic nocturnal enuresis	15
IGF-I assay methods and biologic variability: evaluation of acromegaly treatment response	14
Erratum to: “Impact of age on survival in radioiodine refractory differentiated thyroid cancer patients”	14
Sex steroids and androgen biomarkers in the healthy man study: within-person variability and impact of fasting	14
The glucagon receptor antagonist LY2409021 has no effect on postprandial glucose in type 2 diabetes	14
Autoimmune thyroid disease and thyroid function test fluctuations in patients with resistance to thyroid hormone	14
Clinical features of anti-pituitary-specific transcription factor-1 (PIT-1) hypophysitis: a new aspect of paraneoplastic autoimmune condition	14
Association between premature ovarian insufficiency and biological aging	14
Dose–exposure–IGF-I response of once-weekly somapacitan in adults with GH deficiency	14
Altered biomarkers for cardiovascular disease and inflammation in autoimmune Addison's disease – a cross-sectional study	14
Prevalence and clinical correlations of SF3B1 variants in lactotroph tumours	14
Does exercise beneficially affect sex hormones when added to hypo-caloric diets in adults with overweight or obesity? A systematic review and meta-analysis of controlled clinical trials	14
More than a decade of real-world experience of pegvisomant for acromegaly: ACROSTUDY	14
Association of menopausal hormone therapy with risk of cardiovascular disease in Korean women	14
Impact of remission status in endogenous Cushing's syndrome on cancer incidence	14
EJE Prize 2023: genes on steroids—genomic control of hepatic metabolism by the glucocorticoid receptor	14
Clinical and genetic characteristics in patients under 30 years with sporadic pituitary adenomas	14
Testicular volume in 268 children and adolescents followed-up for childhood obesity—a retrospective cross-sectional study	13
Recombinant growth hormone improves growth and adult height in patients with maternal inactivating GNAS mutations	13
Bariatric surgery promotes recruitment of brown fat linked to alterations in the gut microbiota	13
Correction to: Copeptin improves prediction of treatment response in children with monosymptomatic nocturnal enuresis	13
Fetal growth restriction inhibits childhood growth despite catch-up in discordant identical twins: an observational cohort study	13
MANAGEMENT OF ENDOCRINE DISEASE: Dysnatraemia in COVID-19: prevalence, prognostic impact, pathophysiology, and management	13

High prevalence of subnormal testosterone in obese adolescent males: reversal with bariatric surgery	13
Gonadotropic status in adult women with pituitary stalk interruption syndrome	13
Diurnal cortisol features with cardiovascular disease in hypertensive patients: a cohort study	13
Femora of women with premature ovarian insufficiency exhibit reduced strength and misalignment with the transmitted vertical forces from the upper body	13
The American Thyroid Association risk classification of papillary thyroid cancer according to presurgery cytology	12
Clinical and imaging presentations are associated with function in incidental adrenocortical adenomas: a retrospective cohort study	12
Comorbidities in mild autonomous cortisol secretion and the effect of treatment: systematic review and meta-analysis	12
Insulitis in human type 1 diabetes: lessons from an enigmatic lesion	12
Quantification of androgens and their precursors in full-term human placenta	12
MANAGEMENT OF ENDOCRINE DISEASE: Optimal feminizing hormone treatment in transgender people	12
Extensive expertise in endocrinology: glucose-dependent insulinotropic peptide–dependent Cushing's syndrome	12
GLOBAL ENDOCRINOLOGY: Geographical variation in the profile of RET variants in patients with medullary thyroid cancer: a comprehensive review	12
Impact of exenatide on weight loss and eating behavior in adults with craniopharyngioma-related obesity: the CRANIOEXE randomized placebo-controlled trial	12
Single-cell RNA sequencing in silent corticotroph tumors confirms impaired POMC processing and provides new insights into their invasive behavior	12
Low-grade inflammation during the glucocorticoid withdrawal phase in patients with Cushing's syndrome	12
SGA-born adults with postnatal catch-up have a persistently unfavourable metabolic health profile and increased adiposity at age 32 years	12
The power of sample size calculations	11
Circulating adrenomedullin and B-type natriuretic peptide do not predict blood pressure fluctuations during pheochromocytoma resection: a cross-sectional study	11
The glucagon receptor antagonist LY2409021 does not affect gastrointestinal-mediated glucose disposal or the incretin effect in individuals with and without type 2 diabetes	11
Ultrasound features and risk stratification systems to identify medullary thyroid carcinoma	11
Inhaled glucocorticoid-induced metabolome changes in asthma	11
Response to commentary: strengthening endocrinology training: integrating nonclinical competencies, patient, and trainee perspectives for better implementation strategies	11
Differential cardiovascular risks of menopausal hormone therapy: insights from a Korean cohort	11
The 2021 European Group on Graves’ orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves’ orbitopathy	11
Exenatide for diagnosing endogenous hyperinsulinemic hypoglycemia – a randomized placebo-controlled, double-blind, cross-over proof-of-principle study	11
Accelerated MEN2A in homozygous RET carriers in the context of consanguinity	11
Modified-release hydrocortisone is associated with lower plasma renin activity in patients with salt-wasting congenital adrenal hyperplasia	11
Rationale of a lower dexamethasone dose in prenatal congenital adrenal hyperplasia therapy based on pharmacokinetic modelling	11
Recovery of adrenal function after stopping mitotane in patients with adrenocortical carcinoma	11
Circulating cell-free DNA-based biomarkers for prognostication and disease monitoring in adrenocortical carcinoma	11
Characterization of dominant-negative growth hormone receptor variants reveals a potential therapeutic target for short stature	11
Congenital hypogonadotropic hypogonadism in a patient with a de novoPOGZmutation	11
Association between circulating insulin-like growth factor 1 and risk of all-cause and cause-specific mortality	11
Real-life clinical impact of a five-tiered classification of pituitary tumors	11
Gene expression profiling of subcutaneous adipose tissue reveals new biomarkers in acromegaly	10
Randomized double-blind placebo-controlled trial on levothyroxine and liothyronine combination therapy in totally thyroidectomized subjects: the LEVOLIO study	10
Cushing's syndrome in the elderly: data from the European Registry on Cushing's syndrome	10
Retraction of: Conventional steroids vs. dual-release hydrocortisone on metabolic, cardiovascular, and bone outcomes in adrenal insufficiency: a 10-year study	10
The socioeconomic burden of acromegaly	10
Mediation analysis of the testosterone treatment effect to prevent type 2 diabetes in the Testosterone for Prevention of Type 2 Diabetes Mellitus trial	10
Locally advanced pheochromocytoma/paraganglioma exhibit high metastatic recurrence and disease specific mortality rates: long-term follow-up of 283 patients	10
Pancreas transplantation today: quo vadis?	10
Functional evaluation of a novel nonsense variant of the calcium-sensing receptor gene leading to hypocalcemia	10
Convergence between germline and somatic mutations in pancreatic neuroendocrine tumors	10
Letter to the editor: sociodemographic, lifestyle, and medical factors associated with calculated free testosterone concentrations in men: individual participant data meta-analyses	10
Dynamic changes in LH/FSH ratios in infants with normal sex development	10
Glucose pattern in children with classical congenital adrenal hyperplasia: evidence from continuous glucose monitoring	10
A recurrent familial partial lipodystrophy due to a monoallelic or biallelic LMNA founder variant highlights the multifaceted cardiac manifestations of metabolic laminopathies	10
Does diabetes mellitus mitigate the gender gap in COVID-19 mortality?	10
Efficacy and Safety of Medical treatment of Primary Aldosteronism: a real-world data study in Spain	10
Rare ZMPSTE24 variants increase risk of hypertriglyceridemia and metabolic syndrome	10
Long-term mortality and cardiovascular events in patients with unilateral primary aldosteronism after targeted treatments	10